Compass Therapeutics Inc.

08/06/2024 | Press release | Distributed by Public on 08/06/2024 06:50

Compass Therapeutics Completes Patient Enrollment in COMPANION 002, a Randomized Study of CTX 009 in Combination with Paclitaxel, and Provides an Update on the Development Plan[...]